Read the article
Real-world evidence is the latest global topic enabling companies to analyze and review patterns from the clinical records of millions of existing diabetics.
National Doctors’ Day, TTechnology, healthcare, big data analysis (THB) has partnered with the Indian Diabetes Research Association (RSSDI) to develop innovative clinical trends in one of the largest diabetes markets and to use clinical evidence to fuel the diabetes effort. We promote research that does without diabetes. A statement was announced that it will offer personalized care and clinical improvements backed by specific data.
He also said that the real world evidence is the latest global issue enabling companies to analyze and review patterns from the clinical records of millions of existing diabetics. Understand the disease burden of the entire micro-market, the degree of underdiagnosis and under-treatment, lack of compliance, molecular-based patient cohorts and complaints, the drivers of treatment change, the molecular efficacy in the practice and the cost savings. I can do it. The total cost and net clinical improvement underlying treatment and, most importantly, the drivers of improved and worse clinical outcomes in the real world.
In this regard, Lavina Yadav, Head of RWE Strategy and Operations said, “We are honored to work with RSSDI to expand the generation and adoption of real-world evidence for diabetes. Given the size of the country and the extent of the prevalence of diabetes, this collaboration makes India the world’s largest diabetes drug. I believe it has the power to make it a country of origin for research. “
In addition, Dr. Banshi Saboo, President of RSSDI, and Dr. Sanjay Agarwal, Secretary of RSSDI: With RSSDI. Over the next several years, we aim to publish more than 100 research articles, train more than 100,000 doctors, and work with THB to provide evidence-based care to more than 1 million diabetics. “
THB Collaborates With RSSDI To Transform Practical Evidence Research For Diabetes Source link THB Collaborates With RSSDI To Transform Practical Evidence Research For Diabetes
